Phase
Condition
Neoplasm Metastasis
Colon Cancer; Rectal Cancer
Liver Cancer
Treatment
N/AClinical Study ID
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Histologically confirmed colorectal cancer with liver metastasis(all patients shouldhave the pathological report of colorectal cancer. The chances of hepatocellularcarcinoma or metastasis from other primary lesions should be excluded. )
Liver metastasis should be resected with R0 resection and to save enough normal livertissue
Anticipated liver resection: for normal liver, ﹤70%; for liver with cirrhosis, ﹤50%
No metastasis of other organs or lymph nodes in abdominal cavity
No previous use of oxaliplatin and capecitabine, or previous adjuvant treatment endedmore than 6 months
Age 18 to 75 years old
Karnofsky performance status ≥70
Life expectancy of ≥3 month
Bilirubin level < 1.5mg/dL
Serum creatinine <1.0 times ULN
Absolute neutrophil count ≥2000/mm3, platelet>100,000/mm3, Hb>9g/dl
Having signed informed consent
Exclusion
Exclusion Criteria:
previous use of oxaliplatin or fluorouracil-based chemotherapy in 6 months.
No R0 resection or not enough normal liver tissue left
previous radiotherapy of target lesions
accompanied with unresectable other metastasis or malignant pleural fluids or ascites.
complete or uncompleted liver obstruction
peripheral neuropathy(NCI-CTC grade 1 or more)
mental disturbance neuropathy that influence the cognition, including brain metastasis
other serious disease such as uncontrollable active infection, heart infarction with 1year, un controlled hypertension, arrhythmia with high risk, or unstable heartinfarction,heart failure, coronary artery disease, myocardial infarction within thelast 6 months
Other previous malignancy within 5 year, except non-melanoma skin cancer
accompany with other anti-tumor therapies,including immune therapy, intervention orinjection with chemotherapeutical agents into serous cavity, or participating otherclinical trials.
Pregnancy or lactation period
Study Design
Study Description
Connect with a study center
Peking University, School of Oncology
Beijing, Beijing 100036
ChinaActive - Recruiting
Peking University, People's Hospital
Beijing, 100044
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.